Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records (Q31131489)

12 August 2017

Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records (English)

1 reference

12 August 2017

Noboru Kitamura

1

1 reference

12 August 2017

Yasuo Takahashi

series ordinal

2

1 reference

12 August 2017

Shuukoh Yamadate

series ordinal

3

1 reference

12 August 2017

Satoshi Asai

series ordinal

4

1 reference

12 August 2017

language of work or name

English

0 references

publication date

29 September 2007

1 reference

Cardiovascular Diabetology

12 August 2017

1 reference

12 August 2017

6

1 reference

12 August 2017

26

1 reference

https://scigraph.springernature.com/pub.10.1186/1475-2840-6-26

12 August 2017

0 references

cites work

Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098751

Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098751

Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098751

Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098751

An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3-L1 adipocytes.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098751

Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098751

The renin-angiotensin-aldosterone system: a specific target for hypertension management

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098751

Crosstalk between insulin and angiotensin II signalling systems

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098751

Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098751

Insulin sensitivity in the pathogenesis of hypertension and hypertensive complications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098751

ACE inhibition improves insulin-sensitivity in aged insulin-resistant hypertensive patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098751

Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098751

Effects of antihypertensive therapy on insulin resistance

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098751

Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098751

Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098751

Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098751

Treatment with a beta-blocker with beta 2-agonism improves glucose and lipid metabolism in essential hypertension

25 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17903269

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17903269

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1475-2840-6-26

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference

12 August 2017

1 reference